CIK 0001061983 · Large accelerated filer
CYTOKINETICS INC
Sign in to watch- Ticker
- CYTK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 943291317
- Phone
- (650) 624-3000
- Business address
- 350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,208,275
- in 16 filings, $12.2M under 10b5-1 plans
Net −$12,208,275. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-09 | PARSHALL B LYNNE Director | Sale 10b5-1 | −2,445 | $54.17 | $132K | 8,339 |
| 2026-11-09 | PARSHALL B LYNNE Director | Sale 10b5-1 | −2,555 | $55.26 | $141K | 5,784 |
| 2026-11-03 | Malik Fady Ibraham EVP Research & Development | Sale 10b5-1 | −3,500 | $62.93 | $220K | 153,902 |
| 2026-11-02 | Blum Robert I President & CEO | Sale 10b5-1 | −7,500 | $62.81 | $471K | 278,544 |
| 2026-10-20 | Malik Fady Ibraham EVP Research & Development | Sale 10b5-1 | −3,500 | $64.01 | $224K | 153,902 |
| 2026-10-12 | Blum Robert I President & CEO | Sale 10b5-1 | −7,500 | $62.88 | $472K | 278,544 |
| 2026-10-06 | Malik Fady Ibraham EVP Research & Development | Sale 10b5-1 | −3,500 | $61.38 | $215K | 153,902 |
| 2026-09-28 | Blum Robert I President & CEO | Sale 10b5-1 | −7,500 | $65.46 | $491K | 278,544 |
| 2026-09-22 | Malik Fady Ibraham EVP Research & Development | Sale 10b5-1 | −3,500 | $68.29 | $239K | 153,902 |
| 2026-09-15 | Landry Robert E Director | Sale 10b5-1 | −1,000 | $72.13 | $72K | 8,184 |
| 2026-09-15 | Blum Robert I President & CEO | Sale 10b5-1 | −97,926 | $69.33 | $6.8M | 0 |
| 2026-09-14 | Blum Robert I President & CEO | Sale 10b5-1 | −7,500 | $73.44 | $551K | 377,820 |
| 2026-09-11 | Landry Robert E Director | Sale 10b5-1 | −1,000 | $74.66 | $75K | 9,184 |
| 2026-09-08 | Malik Fady Ibraham EVP Research & Development | Sale 10b5-1 | −3,500 | $75.46 | $264K | 153,902 |
| 2026-09-01 | PARSHALL B LYNNE Director | Sale 10b5-1 | −5,000 | $71.48 | $357K | 10,784 |
| 2026-08-31 | Callos Andrew EVP, Chief Commercial Officer | Sale 10b5-1 | −10,000 | $70.24 | $702K | 58,555 |
| 2026-08-31 | Blum Robert I President & CEO | Sale 10b5-1 | −7,500 | $70.24 | $527K | 377,820 |
| 2026-08-18 | Malik Fady Ibraham EVP Research & Development | Sale 10b5-1 | −3,500 | $75.82 | $265K | 153,902 |
| 2026-08-10 | Blum Robert I President & CEO | Sale 10b5-1 | −7,500 | $76.76 | $576K | 377,820 |
| 2026-07-30 | Callos Andrew EVP, Chief Commercial Officer | Sale 10b5-1 | −14,000 | $79.88 | $1.1M | 58,555 |
Page 1 of 7 · 131 trades